HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).

Abstract
USP7, which encodes a deubiquitylating enzyme, is among the most frequently mutated genes in pediatric T-ALL, with somatic heterozygous loss-of-function mutations (haploinsufficiency) predominantly affecting the subgroup that has aberrant TAL1 oncogene activation. Network analysis of > 200 T-ALL transcriptomes linked USP7 haploinsufficiency with decreased activities of E-proteins. E-proteins are also negatively regulated by TAL1, leading to concerted down-regulation of E-protein target genes involved in T-cell development. In T-ALL cell lines, we showed the physical interaction of USP7 with E-proteins and TAL1 by mass spectrometry and ChIP-seq. Haploinsufficient but not complete CRISPR knock-out of USP7 showed accelerated cell growth and validated transcriptional down-regulation of E-protein targets. Our study unveiled the synergistic effect of USP7 haploinsufficiency with aberrant TAL1 activation on T-ALL, implicating USP7 as a haploinsufficient tumor suppressor in T-ALL. Our findings caution against a universal oncogene designation for USP7 while emphasizing the dosage-dependent consequences of USP7 inhibitors currently under development as potential cancer therapeutics.
AuthorsTimothy I Shaw, Li Dong, Liqing Tian, Chenxi Qian, Yu Liu, Bensheng Ju, Anthony High, Kanisha Kavdia, Vishwajeeth R Pagala, Bridget Shaner, Deqing Pei, John Easton, Laura J Janke, Shaina N Porter, Xiaotu Ma, Cheng Cheng, Shondra M Pruett-Miller, John Choi, Jiyang Yu, Junmin Peng, Wei Gu, A Thomas Look, James R Downing, Jinghui Zhang
JournalScientific reports (Sci Rep) Vol. 11 Issue 1 Pg. 5154 (03 04 2021) ISSN: 2045-2322 [Electronic] England
PMID33664368 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • TAL1 protein, human
  • USP7 protein, human
  • Ubiquitin-Specific Peptidase 7
Topics
  • CRISPR-Cas Systems (genetics)
  • Cell Line, Tumor
  • Cell Lineage (genetics)
  • Cell Proliferation (genetics)
  • Gene Expression Regulation, Leukemic (genetics)
  • Haploinsufficiency (genetics)
  • Humans
  • Oncogenes (genetics)
  • Pediatrics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (genetics, pathology)
  • T-Cell Acute Lymphocytic Leukemia Protein 1 (genetics)
  • Transcriptional Activation (genetics)
  • Ubiquitin-Specific Peptidase 7 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: